By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Boehringer Ingelheim Fremont Inc. 

6701 Kaiser Drive

Fremont  California  94555  U.S.A.
Phone: 510-608-6500 Fax: n/a
bioxcellence@boehringer-ingelheim.com



SEARCH JOBS

Boehringer Ingelheim BioXcellence™ is a leading biopharmaceutical contract manufacturer—a strategic partner you can trust, from development to fill and finish.

We offer tailor-made contract development and manufacturing services to the biopharmaceutical industry, providing the entire production technology chain from DNA to fill and finish under one roof at our facilities in Biberach (Germany), Vienna (Austria), Fremont (USA) and Shanghai (China).

Boehringer Ingelheim has an extraordinarily long history in the field of biotechnology, having been in the industry for 35 years and in contract manufacturing since 1995. During that time we have helped our customers to bring more than 25 molecules to the market. This has earned us a reputation as one of the most experienced and reliable contract manufacturing organizations (CMO) in the world.

Boehringer Ingelheim BioXcellence™ can secure product supply throughout the entire product lifecycle—transferring customer projects at any stage, delivering to almost any scale and thereby makes outsourcing easy.

As an independent, family-owned company, Boehringer Ingelheim is financially sound and stable. This makes us a long-term partner that relies on secure supply.

We are committed to contract manufacturing as one of Boehringer Ingelheim's strategic pillars and priorities and therefore are willing to invest in the newest technologies and facilities to fit your product requirements.

Please click HERE to learn more about careers in Fremont.

Check out Boehringer Ingelheim's YouTube channel.


Key Statistics


Email: bioxcellence@boehringer-ingelheim.com
Ownership: Private

Web Site: Boehringer Ingelheim Fremont
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
Currently No News Articles
//-->